In the second study, genome sequencing on skin and leukemia cells from a woman who died at age 42 after developing breast and ovarian cancer and then leukemia allowed researchers to identify a novel deletion of 3 exons of the TP53 gene [25]. The gene discussed is TP53; the disease is leukemia.